Surgical therapy for Parkinson's disease

European Journal of Neurology

Volumn 9, Issue SUPPL. 3, 2002, Pages 31-39

  Olanow, C Warren ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Deep brain stimulation; Gene therapy; Pallidotomy; Parkinson's disease; Stem cells; Surgery; Transplantation; Trophic factors

Indexed keywords

LEVODOPA; NEURITE PROMOTING FACTOR;

BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN SURGERY; CLINICAL TRIAL; DISEASE COURSE; DYSKINESIA; FETAL TISSUE TRANSPLANTATION; GENE THERAPY; GLOBUS PALLIDUS; HUMAN; NONHUMAN; PALLIDOTOMY; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; STEM CELL; SUBTHALAMIC NUCLEUS; SUBTHALAMOTOMY; SURGICAL TECHNIQUE; THALAMOTOMY; TREATMENT OUTCOME;

BRAIN TISSUE TRANSPLANTATION; CATHETER ABLATION; ELECTRIC STIMULATION THERAPY; ELECTRODES, IMPLANTED; FETAL TISSUE TRANSPLANTATION; FUNCTIONAL LATERALITY; GLOBUS PALLIDUS; HUMANS; NEUROSURGICAL PROCEDURES; PARKINSON DISEASE; SUBTHALAMIC NUCLEUS; THALAMUS;

EID: 0036460440     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.9.s3.4.x     Document Type: Review

References (109)

1. Albin RL, Young AB, Penney JB (1989). The functional anatomy of basal ganglia disorders. Trends Neurosciences 12:366-375.
2. Alvarez L, Macias R, Guridi J et al. (2001). Dorsal subthalamotomy for Parkinson's disease. Movement Disorders 16:72-78.
3. Aziz TZ, Pegg SD, Agarwal E et al. (1992). Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. Br J Neurosurg 6:575-582.
4. Bakay RAE, DeLong MR, Vitek JL (1992). Posteroventral pallidotomy for Parkinson's disease. Neurosurgery 77:487-488.
5. Bankiewicz KS, Plunkett RJ, Jacobawitz DM et al. (1990). The effect of fetal mesencephalon implants on primate MPTP-induced parkinsonism. J Neurosurgery 72:231-244.
6. Baron MS, Vitek JL, Bakay RAE et al. (1996). Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-Year results of a pilot study. Ann Neurol 40:355-366.
7. Bejjani BP, Damier P, Arnulf I et al. (1997). Pallidal stimulation for Parkinson's disease. Two targets? Neurology 49:1564-1569.
8. Bejjani BP, Damier P, Arnulf I et al. (1998). Deep brain stimulation in Parkinson's disease: Opposite effects of stimulation in the pallidum. Movement Disorders 13:969-970.
9. Bejjani BP, Damier P, Arnulf I et al. (1999). Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 340:1476-1480.
10. Benabid AL, Pollak P, Louveau A, Henry S, de Rougemont J (1987). Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson's disease. Appl Neurophysiol 50:344.
11. Benabid AL, Pollak P, Gervason C et al. (1991). Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337:403.
12. Benabid AL, Pollock P, Gao D et al. (1996). Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurgery 84:203-214.
13. Benazzouz A, Gross C, Feger J (1993). Reversal of rigidity and improvement in motor performance by subthalamic highfrequency stimulation in MPTP-treated monkeys. European J Neuroscience 5:382-389.
14. Benazzouz A, Hallett M (2000). Mechanism of action of deep brain stimulation. Neurology 55:13-16.
15. Bergman H, Wichmann T, DeLong MR (1990). Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 249:1436.
16. Bergman H, Wichmann T, Karmon B, DeLong MR (1994). The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 72:507-520.
17. Bjorklund LM, Sanchez-Pernaute R, Chung S et al. (2002). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99:2344-2349.
18. Bjorklund A, Stenevi U (1979). Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555-560.
19. Blond S, Caparros-Lefebvre D, Parker F et al. (1992). Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurgery 77:62.
20. Brotchie JM, Mitchell I J, Sambrook MA, Crossman AR (1991). Alleviation of parkinsonism by antagonist of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Movement Disorders 6:133-138.
21. Caparros-Lefebvre D, Ruchoux MM, Blond S et al. (1994). Long-term thalamic stimulation in Parkinson's disease: Post mortem anatomo-clinical study. Neurology 44:1856-1860.
22. Cooper IS (1956). Ligation of the anterior choroidal artery for involuntary movements of parkinsonism. Arch Neurol 75:36-48.
23. Cooper IS, Bravo G (1958). Chemopallidectomy and chemothalamectomy. J Neurosurgery 15:244.
24. Crossman AR, Mitchell IJ, Sambrook MA (1985). Regional brain uptake of 2-deoxy glucose in MPTP-induced parkinsonism in the Macaque monkey. Neuropharmacology 24:587-591.
25. Cubo E, Gracies JM, Benabou R et al. (2001). Early morning off-medication dyskinesias, dystonia, and choreic subtypes. Arch Neurol 58:1379-1382.
26. Deacon T, Schumacher J, Dinsmore J et al. (1997). Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Med 3:350-353.
27. Defer GL, Geny C, Ficolfi F et al. (1996). Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119:41-50.
28. DeLong MR (1990). Primate models of movement disorders of basal ganglia origin. Trends Neurosciences 13:281-289.
29. Dhawan V, Nakamura T, Margouleff C et al. (1999). Doubleblind controlled trial of human embryonic dopaminergic tissue transplants in advanced Parkinson's disease: Fluorodopa PET imaging. Neurology 52:405.
30. Dogali M, Fazzini E, Kolodny E et al. (1995). Stereotactic ventral pallidotomy for Parkinson's disease. Neurology 45:753-761.
31. Dunnett SB, Hernandez TD, Summerfield A et al. (1988). Graft-derived recovery from 6-OHDA lesions: Specificity of ventral mesencephalic graft tissues. Exp Brain Res 71:411-424.
32. Eidelberg D, Moeller JR, Dhawan V et al. (1994). Metabolic topography of parkinsonism. J Cerebral Blood Flow Metabolism 14:783-801.
33. Fine J, Duff J, Chen R et al. (2000). Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med 342:1708-1714.
34. Fox MW, Ahlskog JE, Kelly PJ (1991). Stereotactic ventrolateralis thalamotomy for medically refractory tremor in postlevodopa era Parkinson's disease patients. J Neurosurgery 75:723.
35. Freed CR, Breeze RE, Rosenberg NI et al. (1992). Survival of implanted fetal dopamine cells and neurologic improvement 12-46 months after transplantation for Parkinson's disease. N Engl J Med 327:1549-1555.
36. Freed CR, Breeze RE, Schnock SA et al. (1994). Human fetal dopamine cells survive and develop processes after implantation into humans with Parkinson's disease. Soc Neuroscience Abstracts 20:9.
37. Freed CR, Greene PE, Breeze RE et al. (2001). Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710-719.
38. Freeman TB, Olanow CW, Hauser RA et al. (1995). Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379-388.
39. Freeman TB, Vawter DE, Leaverton PE et al. (1999). The use of a surgical placebo-control in evaluating cellular-based therapy for Parkinson's disease. N Engl J Med 341:988-992.
40. Gash DM, Zhang Z, Cass WA et al. (1995). Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J Clin Neuroscience 363:345-358.
41. Gash DM, Zhang Z, Ovadia A et al. (1996). Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380:252-255.
42. Goetz CG, Olanow CW, Koller WC et al. (1989). Multicenter study of autologous adrenal medullary transplantation to the corpus striatum in patients with advanced Parkinson's disease. N Engl J Med 320:337-341.
43. Gracies JM, Bucobo JC, Danisi F, Germano IM, Brin M, Olanow CW (1998b). Proposal for a method of stimulation parameter adjustment after deep brain stimulation for Parkinson's disease. Movement Disorders 13:50.
44. Gracies JM, Bucobo JC, Danisi F, Weisz D, Brin MF, Olanow CW (1998a). Paradoxical impact of unilateral subthalamic stimulation on L-dopa treated parkinsonian symptomatology: One case report. Ann Neurol 44:500-501.
45. Greene PE, Fahn S, Tsai WY et al. (1999). Severe spontaneous dyskinesias: A disabling complication of embryonic dopaminergic tissue implants in a subset of transplanted patients with advanced Parkinson's disease. Movement Disorders 14:904.
46. Hamada I, DeLong MR (1992). Excitotoxic acid lesions of the primate subthalamic nucleus results in reduced pallidal neuronal activity during active holding. J Neurophysiol 68:1859-1866.
47. Hauser RA, Freeman TB, Snow BJ et al. (1999). Long-term evaluation of bilateral fetal nigral transplantation in Parkinson's disease. Arch Neurol 56:179-187.
48. Jankovic J, Cardoso F, Grossman RG, Hamilton WJ (1995). Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 37:680-686.
49. Kelly PJ, Gillingham FJ (1980). The long-term results of stereotactic surgery and L-dopa therapy in patients with Parkinson's disease. J Neurosurgery 53:332.
50. Kish SJ, Shannak K, Hornykiewica O (1988). Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. N Engl J Med 318:876-880.
51. Koller W, Pahwa R, Busenbark K et al. (1997). High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 42:292-299.
52. Kordower JH, Emborg ME, Bloch J et al. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773.
53. Kordower JH, Freeman TB, Olanow CW (1998). Neuropathology of fetal nigral grafts in patients with Parkinson's disease. Movement Disorders 13:88-95.
54. Kordower JH, Freeman TB, Snow BJ et al. (1995). Post mortem evidence of dopamine graft survival and striatal reinnervation in a Parkinson's disease patient displaying improved motor function following fetal nigral transplantation. N Engl J Med 332:1118-1124.
55. Kordower JH, Rosenstein JM, Collier TM et al. (1996). Functional fetal nigral grafts in a patient with Parkinson's disease: Chemoanatomic, quantatative, ultrastructural, and metabolic studies. J Clin Neuroscience 370:203-230.
56. Kordower JH, Styren S, DeKosky ST, Olanow CW, Freeman TB (1997). Fetal grafting for Parkinson's disease: Expression of immune markers in two patients with functional fetal nigral implants. Cell Transplantation 6:213-219.
57. Kumar R, Lozano A, Kim YJ et al. (1998). Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 51:850-855.
58. Laitinen LV, Bergenheim AT, Hariz MI (1992a). Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurgery 76:53.
59. Laitinen LV, Bergenheim AT, Hariz MI (1992b). Ventroposterolateral pallidotomy can abolish all parkinsonian symptoms. Stereotactic Func Neurosurgery 58:14.
60. Lang AP, Lozano AE (1998). Parkinson's disease. N Engl J Med 339:1044-1053.
61. Lang AE, Lozano AM, Montgomery E, Duff J, Tasker R, Hutchinson W (1997). Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 337:1036-1042.
62. Limousin P, Krack P, Pollak P et al. (1998). Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 339:1105-1111.
63. Limousin P, Pollack P, Benazzouz A et al. (1995a). Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345:91-95.
64. Limousin P, Pollack P, Hoffmann D et al. (1995b). Abnormal involuntary movements induced by subthalamic nucleus stimulation in Parkinson's disease. Movement Disorders 10:672-674.
65. Lin L-F, Doherty DH, Lile JD et al. (1993). A glial cellline-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
66. Lindsay RM, Wiegand SJ, Altar CA, Distephano PS (1994). Neurotrophic factors: From molecule to man. Trends Neurosciences 17:182-190.
67. Lindvall O, Backlund EO, Farde L et al. (1987). Transplantation in Parkinson's disease: Two cases of adrenal medullary grafts to the putamen. Ann Neurol 22:457-468.
68. Lindvall O, Brundin P, Widner H et al. (1990). Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574-577.
69. Lindvall O, Widner H, Rehncrona S et al. (1992). Transplantation of fetal dopamine neurons in Parkinson's disease: One year clinical and neurophysiological observations in two patients with putaminal implants. Ann Neurol 31:155-165.
70. Madrazo I, Drucker-Colin R, Diaz V et al. (1987). Open microsurgical autograft of adrenal medulla to right caudate nucleus in two patients with intractable Parkinson's disease. N Engl J Med 316:831-834.
71. Martinez-Serrano A, Bjorklund A (1997). Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosciences 20:530-588.
72. Matsumoto K, Shichoijo F, Fukami T (1984). Long-term follow-up review of cases of Parkinson's disease after unilateral or bilateral thalamotomy. J Neurosurgery 60:1033.
73. Meyers R (1942). The modification of altering tremors, rigidity and festination by surgery of the basal ganglia. Research Publications of the Association of Research into Nervous and Mental Disease 21:602.
74. Meyers R (1951). Surgical experiments in the therapy of certain 'extrapyramidal' diseases: A current evaluation. Acta Psychiatrica Neurologica 67:3-31.
75. Narabayshi H (1989). Stereotaxic VIM thalamotomy for treatment of tremor. European Neurol 29:29.
76. Narabayshi H, Maeda T, Yokochi F (1987). Long-term follow-up study of nucleus ventralis intermedius and ventrolateralis thalamotomy using a microelectrode technique in parkinsonism. Appl Neurophysiol 150:330.
77. Narabayshi H, Yokochi F, Nakajima Y (1984). Levodopainduced dyskinesia and thalamotomy. J Neurol, Neurosurgery Psychiatry 47:831.
78. Nutt JG, Anderson VC, Peacock JH (2001). DBS and diathermy interaction induces severe CNS damage. Neurology 56:1384-1386.
79. Obeso JA, Rodriguez-Oroz MC, Rodriguez M et al. (2000a). Pathophysiology of the basal ganglia in PD. Trends Neurosciences 23:8-19.
80. Obeso JA, Rodriguez-Oroz MC, Rodriguez M, DeLong MR, Olanow CW (2000b). Pathophysiology of Levodopa-induced dyskinesias in Parkinson's disease: Problems with the current model. Ann Neurol 47:22-34.
81. Ohye H, Narabayshi H (1979). Physiological study of presumed ventralis intermedius neurons in the human thalamus. J Neurosurgery 50:290.
82. Olanow CW (1996). Pallidotomy - Have we made a dent in Parkinson's disease? Ann Neurol 40:341-343.
83. Olanow CW, Brin MF (2001). Surgery for Parkinson's disease: A physician's perspective. Adv Neurol 86:421-433.
84. Olanow CW, Brin M, Obeso JA (2000). The role of deep brain stimulation as a surgical treatment for Parkinson's disease. Neurology 55:60-66.
85. Olanow CW, Freeman TB, Kordower JH (1996). Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosciences 19:102-109.
86. Olanow CW, Koller W, Goetz CG et al. (1990). Autologous transplantation of adrenal medulla in Parkinson's disease. Arch Neurol 47:1286-1289.
87. Olanow CW, Obeso JA (2000). Preventing levodopa-induced dyskinesia. Ann Neurol 47:167-178.
88. Olanow CW, Watts RL, Koller WC (2001). An algorithm (decision tree) for the management of Parkinson's disease (2001): Treatment guidelines. Neurology 56:1-88.
89. Page RD (1992). The use of thalamotomy in the treatment of levodopa-induced dyskinesia. Acta Neurochirurgica 114:77.
90. Pahwa R, Wilkinson S, Smith RN, Lyons K, Koller WC (1997). High-frequency stimulation of the pallidus for the treatment of Parkinson's disease. Neurology 49:249-253.
91. Perlow MJ, Freed WJ, Hoffer BJ et al. (1979). Brain grafts reduce motor abnormalities produced by destruction of nigro-striatal dopamine system. Science 204:643-647.
92. Peschanski M, Defer G, N'Guven JP et al. (1994). Bilateral motor improvement and alteration of L-dopa effect in two patients with Parkinson's disease following intrastriatal transplantation of fetal ventral mesencephalon. Brain 117:487-499.
93. Piallat B, Benazzouz A, Benabid AL (1996). Subthalamic nucleus lesion on rats prevents dopaminergic nigral neuron degeneration after striatal 6-OHDA injection: Behavioural and immunohistochemical studies. European J Neuroscience 8:1408-1414.
94. Redmond DE, Roth RH, Elsworth JD et al. (1986). Fetal neuronal grafts in monkeys given methyl-phenyl-tetrahydro-pyridine. Lancet 1:1125-1127.
95. Remy P, Samson Y, Hantrave P et al. (1995). Clinical correlates of [18F] fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 38:580-588.
96. Rodriguez MC, Obeso JA, Olanow CW (1998). Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease; a target for neuroprotection. Ann Neurol 44:175-188.
97. Samii A, Turnbull IM, Kishore A et al. (1999). Reassessment of unilateral pallidotomy in Parkinson's disease. A 2-year follow-up study. Brain 122:417-425.
98. Sawle GV, Bjorklund A et al. (1992). Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants. Ann Neurol 31:166-173.
99. Schuurman PR, Bosch A, Bossuyt PMM et al. (2002). A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med 342:461-468.
100. Sellal F, Hirsch E, Livoski F et al. (1992). Contralateral disappearance of parkinsonian signs after subthalamic hematoma. Neurology 42:255.
101. Siegfried J, Lippitz B (1994). Bilateral chronic stimulation of ventroposterolateral pallidum: New therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 35:1126-1129.
102. Spencer DD, Robbins RJ, Naftolin F et al. (1992). Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541-1548.
103. Spiegel EA, Wycis HT, Marks M, Lee AJ (1947). Stereotaxic apparatus for operations on the human brain. Science 106:349.
104. Svendsen CN, Smith AG (1999). New prospects for human stem-cell therapy in the nervous system. Trends Neurosciences 22:357-364.
105. Tasker RR (1967). Surgical aspects symposium on extrapyramidal diseases. Appl Therapeutics 9:454.
106. Tasker RR, Siqueira J, Hawrylshyn P et al. (1983). What happened to VIM thalamotomy for Parkinson's disease? Appl Neurophysiol 146:68.
107. The Deep Brain Stimulation for PD Study Group (2001). Deep brain stimulation of the subthalamic nucleus or globus pallidus pars interna in Parkinson's disease. N Engl J Med 345:956-963.
108. Volkmann J, Sturm V, Waiss P et al. (1998). Bilateral high frequency stimulation of the internal globus pallidus in advanced Parkinson's disease. Ann Neurol 44:953-961.
109. Wenning GK, Odin P, Morrish P et al. (1997). Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann Neurol 42:95-107.